Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Otorhinolaryngology

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 60 articles: HTML format

Single Articles

July 2025
1. JAINAR CJE, Jacomina LE, Dee EC, Lee A, et al
   Global Disparities in Current Clinical Trials in Nasopharyngeal Carcinoma.
   Int J Radiat Oncol Biol Phys. 2025 Jul 2:S0360-3016(25)04511.
   PubMed     Abstract available
   
   
   June 2025
2. JIANG M, Li H, Chen C, Li Y, et al
   Post-Irradiation Otitis Media with Effusion in Nasopharyngeal Carcinoma: A Comprehensive Review of Pathogenesis, Management, and Prevention.
   Int J Radiat Oncol Biol Phys. 2025 Jun 27:S0360-3016(25)04517.
   PubMed     Abstract available
   
   
   
3. YILMAZ MT, Cengiz M, Kahvecioglu A, Yigit E, et al
   Fifteen Years of Experience with Stereotactic Body Radiotherapy for Recurrent Head and Neck Cancers: A Detailed Analysis of Patients with Carotid Blowout Syndrome.
   Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04486.
   PubMed     Abstract available
   
   
   
4. GALLOWAY TJ, Pugh SL, Ridge JA, Nguyen-Tan PF, et al
   Long term feeding tube use in head and neck cancer survivors - a secondary analysis of patient and treatment related factors.
   Int J Radiat Oncol Biol Phys. 2025 Jun 3:S0360-3016(25)00527.
   PubMed     Abstract available
   
   
   
5. KISER KJ, Apicelli AJ, Brenneman RJ, Contreras JA, et al
   Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral Neck.
   Int J Radiat Oncol Biol Phys. 2025 Jun 2:S0360-3016(25)00552.
   PubMed    
   
   
   
6. MCDOWELL L, Gough K, Fua T, Coleman A, et al
   Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy.
   Int J Radiat Oncol Biol Phys. 2025;122:355-364.
   PubMed     Abstract available
   
   
   May 2025
7. LIN SJ, Guo QJ, Liu Q, Ng WT, et al
   International Consensus Guideline on Delineation of the Clinical Target Volumes (CTV) at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).
   Int J Radiat Oncol Biol Phys. 2025 May 24:S0360-3016(25)00487.
   PubMed     Abstract available
   
   
   
8. LIU Y, Men Y, Bao Y, Ma Z, et al
   Neoadjuvant immunochemoradiotherapy versus chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis of reconstructed individual patient data.
   Int J Radiat Oncol Biol Phys. 2025 May 2:S0360-3016(25)00387.
   PubMed     Abstract available
   
   
   
9. KUIJER KM, Smits HJG, Doornaert PAH, Niu K, et al
   Comparable Performance Between Automatic and Manual Laryngeal and Hypopharyngeal Gross Tumor Volume Delineations Validated With Pathology.
   Int J Radiat Oncol Biol Phys. 2025;122:186-193.
   PubMed     Abstract available
   
   
   April 2025
10. MEHANNA H, Abou-Foul AK, Henson C, Kristunas C, et al
    Accuracy and Prognosis of Extranodal Extension on Radiologic Imaging in Human Papillomavirus-Mediated Oropharyngeal Cancer: a Head and Neck Cancer International Group (HNCIG) real-world study.
    Int J Radiat Oncol Biol Phys. 2025 Apr 24:S0360-3016(25)00370.
    PubMed     Abstract available
    
    
    
11. MARCHETTI M, Pinzi V, Gemma M, Cuccarini V, et al
    Hypo-fractionated versus single-session radiosurgery to preserve hearing in patients affected by sporadic vestibular schwannoma. The ACOUNEU randomized clinical trial.
    Int J Radiat Oncol Biol Phys. 2025 Apr 11:S0360-3016(25)00359.
    PubMed     Abstract available
    
    
    
12. HUANG Z, Li Y, Wu W, Wu L, et al
    Plasma Epstein-Barr virus DNA Temporal Clearance Pattern During Induction-concurrent (Chemo)radiotherapy for Risk Stratification in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025 Apr 7:S0360-3016(25)00349.
    PubMed     Abstract available
    
    
    
13. MCBRIDE SM
    Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?
    Int J Radiat Oncol Biol Phys. 2025;121:1207-1208.
    PubMed    
    
    
    March 2025
14. SHI JJ, Meduri K, Liao CY, Moon D, et al
    Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study.
    Int J Radiat Oncol Biol Phys. 2025 Mar 29:S0360-3016(25)00313.
    PubMed     Abstract available
    
    
    
15. MORSE RT, Nelson TJ, Liu HC, Sangchan P, et al
    Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk.
    Int J Radiat Oncol Biol Phys. 2025;121:684-692.
    PubMed     Abstract available
    
    
    February 2025
16. GARRIDO-HERNANDEZ G, Ytre-Hauge KS, Winter RM, Danielsen S, et al
    In silico interim adaptation of proton therapy in head and neck cancer by simultaneous dose and linear energy transfer escalation.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00154.
    PubMed     Abstract available
    
    
    
17. YANG L, Liu X, Li Z, Li Z, et al
    Multimodal Image Confidence: A Novel Method for Tumor and Organ Boundary Representation.
    Int J Radiat Oncol Biol Phys. 2025;121:558-569.
    PubMed     Abstract available
    
    
    
18. SANTOS M, Oliveira E Silva LF, Kohler HF, Curioni O, et al
    Erratum to: Santos M, Oliveira e Silva LF, Kohler HF, et al. Health-Related Quality of Life Outcomes in Head and Neck Cancer: Results From a Prospective, Real-World Data Study With Brazilian Patients Treated With Intensity Modulated Radiation Therapy,
    Int J Radiat Oncol Biol Phys. 2025;121:573.
    PubMed    
    
    
    
19. BIN-ALAMER O, Trifiletti DM, Sheehan JP
    Neurologic Outcomes in Vestibular Schwannoma Management: Comparative Analysis of the VISAS and V-REX Studies: Early Treatment Likely Proves More Beneficial.
    Int J Radiat Oncol Biol Phys. 2025;121:481-483.
    PubMed    
    
    
    January 2025
20. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    PubMed     Abstract available
    
    
    
21. DAMEN PJJ, Peters M, Hobbs B, Chen Y, et al
    Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jan 2:S0360-3016(24)03770.
    PubMed     Abstract available
    
    
    
22. SANGUINETI G, D'Urso P, Bottero M, Farneti A, et al
    Stereotactic Radiation Therapy in 3 Fractions for T1 Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2025;121:145-152.
    PubMed     Abstract available
    
    
    
23. RAJENDRAN P, Chen Y, Qiu L, Niedermayr T, et al
    Autodelineation of Treatment Target Volume for Radiation Therapy Using Large Language Model-Aided Multimodal Learning.
    Int J Radiat Oncol Biol Phys. 2025;121:230-240.
    PubMed     Abstract available
    
    
    
24. NG WT, Huang SH, Henson C, Bakst RL, et al
    Looking Forward and Looking Back: Cutting-Edge Advances and Long-Standing Controversies in Head and Neck Cancer Management.
    Int J Radiat Oncol Biol Phys. 2025;121:1-7.
    PubMed    
    
    
    December 2024
25. YANG YX, Yang X, Jiang XB, Lin L, et al
    Artificial Intelligence-Empowered Multistep Integrated Radiation Therapy Workflow for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Dec 19:S0360-3016(24)03670.
    PubMed     Abstract available
    
    
    
26. GUO R, Zhang WW, Lv JW, Lin JY, et al
    Long-term Outcomes Following Individualized Elective Primary Tumor CTV Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Dec 17:S0360-3016(24)03727.
    PubMed     Abstract available
    
    
    
27. GUO Q, Huang J, Xiao N, Zhou F, et al
    Long-term outcome in cervical lymph node-positive nasopharyngeal carcinoma following IMRT with one-step cervical nodal CTV delineation by geometric-anatomic expansion from nodal GTV: A double-center experience.
    Int J Radiat Oncol Biol Phys. 2024 Dec 12:S0360-3016(24)03723.
    PubMed     Abstract available
    
    
    
28. GRIPPIN A, Kim A, Liu Y, Copling S, et al
    Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies.
    Int J Radiat Oncol Biol Phys. 2024 Dec 12:S0360-3016(24)03724.
    PubMed     Abstract available
    
    
    
29. RUHLE A
    Stick Your Neck Out: Reirradiate or Not in a Head and Neck Cancer Patient With Extracapsular Extension After Salvage Neck Dissection.
    Int J Radiat Oncol Biol Phys. 2024;120:1205-1206.
    PubMed    
    
    
    November 2024
30. THARIAT J, Bosset M, Falcoz A, Vernerey D, et al
    Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR.
    Int J Radiat Oncol Biol Phys. 2024 Nov 27:S0360-3016(24)03651.
    PubMed     Abstract available
    
    
    
31. LUO X, Wang H, Xu J, Li L, et al
    Generalizable MRI-based Nasopharyngeal Carcinoma Delineation: Bridging Gaps across Multiple Centers and Raters with Active Learning.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03644.
    PubMed     Abstract available
    
    
    
32. WANG L, Wang J, Wang T, Li Y, et al
    The Role of Elective Nodal Irradiation in Treating Clinically Node-Negative Sinonasal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;120:1058-1065.
    PubMed     Abstract available
    
    
    
33. MCDOWELL L, King MT, Hutcheson KA, Ringash J, et al
    A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials.
    Int J Radiat Oncol Biol Phys. 2024;120:805-822.
    PubMed     Abstract available
    
    
    October 2024
34. ZHANG X, Yan J, Lei Q, Neo J, et al
    A Randomised, Multicentre, Phase II Trial of Camrelizumab with or without Metastasis-directed Stereotactic Body Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Oct 23:S0360-3016(24)03512.
    PubMed     Abstract available
    
    
    
35. LIAN B, Yang Y, Zheng B, Si L, et al
    Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined Analysis.
    Int J Radiat Oncol Biol Phys. 2024;120:528-536.
    PubMed     Abstract available
    
    
    September 2024
36. CAI G, Wang K, Zhao J, Huang B, et al
    Predictive value of changes in basal myocardial (18)F-fluorodeoxyglucose uptake for cardiotoxicity in locally advanced esophageal cancer patients receiving definitive radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Sep 20:S0360-3016(24)03403.
    PubMed     Abstract available
    
    
    
37. CHARTERS E, Davies S, Sharman AR, Milross C, et al
    Keeping Swallowing on Track During Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:29-32.
    PubMed    
    
    
    
38. JACOMINA LE, Moreno AC
    Management of Patients With Early-Stage Oropharyngeal Cancer With Clinically Positive Retropharyngeal Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2024;120:13-14.
    PubMed    
    
    
    
39. WOODY NM
    Spare the Knife When Retropharyngeal Lymph Nodes Are Present in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:13.
    PubMed    
    
    
    August 2024
40. CHU H, de Vette SPM, Neh H, Sijtsema NM, et al
    3D deep learning Normal Tissue Complication Probability model to predict late xerostomia in head and neck cancer patients.
    Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03172.
    PubMed     Abstract available
    
    
    July 2024
41. NORONHA V, Patil V, Menon N, Singh A, et al
    Long term update of a phase 3 randomized study comparing once-a-week versus once-every-3-weeks cisplatin along with radiation in head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jul 27:S0360-3016(24)03139.
    PubMed     Abstract available
    
    
    
42. SHER DJ, Avkshtol V, Moon D, Vo D, et al
    Stereotactic ablative radiotherapy for T1-2 glottic larynx cancer: mature results from the phase II LT-SABR trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 20:S0360-3016(24)02972.
    PubMed     Abstract available
    
    
    
43. LI JS, Blanchard P, Wong CHL, Ahn YC, et al
    International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Jul 13:S0360-3016(24)02954.
    PubMed     Abstract available
    
    
    
44. LI W, Zhao D, Zeng G, Chen Z, et al
    Evaluating Virtual Contrast-enhanced MRI (VCE-MRI) in Nasopharyngeal Carcinoma Radiotherapy: A Retrospective Analysis for Primary Gross Tumor Delineation.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00750.
    PubMed     Abstract available
    
    
    
45. KATADA C, Yokoyama T, Watanabe A, Hara H, et al
    Optimizing Organ Preservation Strategies through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results from the CROC Multi-Institutional Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00752.
    PubMed     Abstract available
    
    
    
46. MORSE RT, Mell LK
    Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
    Int J Radiat Oncol Biol Phys. 2024;119:783-785.
    PubMed    
    
    
    June 2024
47. CHEN B, Chen W, Cheng Q, Zhang H, et al
    Comparison of efficacy and safety of combined chemoimmunotherapy with or without radiotherapy for stage IVB esophageal squamous cell carcinoma: a multicenter propensity score matching analysis.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00741.
    PubMed     Abstract available
    
    
    
48. ZHANG Z, Zhang J, Zheng R, Ye J, et al
    A Population-Based Tumor-Volume Model for Head-and-Neck Cancer During Radiotherapy with a Dynamic Oxygenated Compartment.
    Int J Radiat Oncol Biol Phys. 2024 Jun 11:S0360-3016(24)00684.
    PubMed     Abstract available
    
    
    May 2024
49. CHU Y, Zhu C, Hobbs BP, Chen Y, et al
    Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia among Esophageal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00668.
    PubMed     Abstract available
    
    
    
50. MCVORRAN S, Naghavi A, Schaner P
    Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?
    Int J Radiat Oncol Biol Phys. 2024;119:302-303.
    PubMed    
    
    
    April 2024
51. BIN-ALAMER O, Abou-Al-Shaar H, Peker S, Samanci Y, et al
    Vestibular Schwannoma International Study of Active Surveillance Versus Stereotactic Radiosurgery: the VISAS Study.
    Int J Radiat Oncol Biol Phys. 2024 Apr 6:S0360-3016(24)00482.
    PubMed     Abstract available
    
    
    
52. SMITH J, Margalit D, Golledge J, Nastasi D, et al
    Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00474.
    PubMed     Abstract available
    
    
    
53. HIROSE K, Sato M
    Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.
    Int J Radiat Oncol Biol Phys. 2024 Apr 3:S0360-3016(24)00466.
    PubMed     Abstract available
    
    
    
54. HOMMA A, Mikami M, Matsuura K, Onimaru R, et al
    Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients wi
    Int J Radiat Oncol Biol Phys. 2024;118:1271-1281.
    PubMed     Abstract available
    
    
    
55. BUDRUKKAR A, Murthy V, Kashid S, Swain M, et al
    Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:1541-1551.
    PubMed     Abstract available
    
    
    March 2024
56. YOUSSEF I, Mohamed N, Kallini D, Zakeri K, et al
    An Analysis of PET Maximum SUV Among Head and Neck Cancer Patients Receiving Photon and Proton Radiation.
    Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00428.
    PubMed     Abstract available
    
    
    
57. CHEN M, Wang K, Wang J
    Vision Transformer-Based Multilabel Survival Prediction for Oropharynx Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1123-1134.
    PubMed     Abstract available
    
    
    
58. DENG J, Dietrich MS, Aulino JM, Sinard RJ, et al
    Longitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2024;118:1029-1040.
    PubMed     Abstract available
    
    
    
59. MCDOWELL L, Gough K, Fua T, Coleman A, et al
    A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:1018-1028.
    PubMed     Abstract available
    
    
    
60. ZHANG S, Li K, Sun Y, Wan Y, et al
    Deep learning for automatic gross tumor volumes contouring in esophageal cancer based on contrast-enhanced CT images: a multi-institutional study.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00350.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.